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ABSTRACT 
Ionic substitutions have been proposed as a tool to control the functional 
behavior of synthetic hydroxyapatite (HA), particularly for Bone Tissue Engineering 
(BTE) applications. The effect of simultaneous substitution of different levels of 
carbonate (CO3) and silicon (Si) ions in the HA lattice was investigated. Furthermore, 
human bone marrow-derived mesenchymal stem cells (hMSCs) were cultured on 
multi-substituted HA (SiCHA) to determine if biomimetic chemical compositions 
were osteoconductive. Of the four different compositions investigates, SiCHA-1 
(0.58wt% Si) and SiCHA-2 (0.45wt% Si) showed missing bands for CO3 and Si using 
FTIR analysis, indicating competition for occupation of the phosphate site in the HA 
lattice. 500°C was considered the most favourable calcination temperature as: (i) the 
powders produced possessed a similar amount of CO3 (2-8wt%) and Si (<1.0wt%) as 
present in native bone; and (ii) there was a minimal loss of CO3 and Si from the HA 
structure to the surroundings during calcination. Higher Si content in SiCHA-1 led to 
lower cell viability and at most hindered proliferation, but no toxicity effect occurred. 
While, lower Si content in SiCHA-2 showed the highest ALP/DNA ratio after 21 days 
culture with hMSCs, indicating that the powder may stimulate osteogenic behaviour 
to a greater extent than other powders.  
 
Key Words: hydroxyapatite, carbonate, silicon, in vitro test, human mesenchymal 
stem cells 
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INTRODUCTION 
In the 1980’s, Hydroxyapatite (HA) was considered to be the material of 
choice for the development of bone substitutes to repair bone fractures and other 
defects due to its strong affinity with the mineral constituents of bones, good 
bioactivity, osteoconductivity and biocompatibility with the human bone tissue [1-5]. 
Although, stoichiometric HA, composed of calcium (Ca), phosphates (PO4) and 
hydroxyl (OH) groups [Ca10  (PO4)6 (OH)2], the chemical composition of biological 
apatites differs from the stoichiometric HA [6-9]. The biological apatites are uniquely 
similar in that they all comprise carbonate (CO3) in varying amounts of 2-8wt%, 
preferentially substituting the phosphate site (B-type) compared with hydroxyl (A-
type) ions in the apatite lattice [9-13]. The composition of CO3 depends on bone age, 
site, sex and health of the individual [8, 14, 15]. 
The beneficial impact of CO3 substitution into phosphate and/or hydroxyl site 
in HA structure has been reported in the literature. For instance, the presence of B-
type CO3-HA (CHA) has been shown to cause a decrease in crystallinity and enhance 
solubility both in vitro and in vivo [6, 16, 17]. In vivo tests using an ovine model 
demonstrated that more dissolution was observed from the CHA at the bone implant 
interface and within the implant, when compared to pure HA [18].  
Among other trace elements present in natural bone, silicon (Si) plays an 
important role in early stage of bone formation [5, 19]. Back in 1970’s, Carlisle found 
that Si deficiency resulted in abnormal bone formation and this finding was supported 
by Schwartz & Milne who confirmed that Si play an important role as cross-linking 
agent in connective tissue and its importance to vascular health [20, 21]. Si also plays 
an important role in bone metabolism [20, 22]. At physiological levels, soluble Si was 
reported to enhance osteoblastic cell proliferation and differentiation [23], stimulates 
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the enzymes involved in collagen type I synthesis [19] and increases the bone mineral 
density (BMD) [24]. However, there is still a discrepancy on the effect of Si-
substituted HA (SiHA) on biological responses, which has been reported in the 
literature. This is mainly because Si substitution into HA lattice is known to have a 
dose-dependent effect on the proliferation, differentiation and collagen synthesis of 
osteoblast, with a direct influence on the remodelling process and osteoclast 
development and resorption activities [8, 24-26]. 
In this context, we are now focussing on the development of silicon-
carbonated HA (SiCHA) powders with a fully controlled level of CO3- and Si- 
substitutions into the HA structure as this may result in synergy between the 
bioresorbable properties of CHA and the release of soluble Si [15, 26]. To date, 
several studies on the development of SiCHA powders focused on different synthesis 
techniques, physico-chemical characterizations and some solubility tests in simulated 
body fluid (SBF) to predict the ability to form apatite layer in vitro [6, 7, 27-29]. 
However, to our knowledge, limited investigations have considered the cell responses. 
Recently, Landi and colleagues have highlighted the benefits of CHA, SiHA and 
SiCHA in stimulating better cell responses compared to HA alone, where high Si 
content (0.88wt%) substituted the HA lattice was found to cause a toxic effect to 
human osteoblasts cells [8]. Even though these bioceramics are easily producible by 
both dry and wet chemical method and appear to be biocompatible in their bulk form, 
knowledge concerning the effect of ionic substitutions into the HA structure and their 
releases to the surrounding cells during culture are still lacking. Therefore, the aim of 
the present study was to develop SiCHA powders with controlled amounts of CO3- 
and Si-substituted into the apatite structure to closely mimic the range of 
compositions observed within bone mineral and investigated the effect of ionic 
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substitutions in response to human bone marrow derived-mesenchymal stem cells to 
finally select the most osteoconductive powders as the potential biomedical materials 
for BTE applications.  
 
MATERIALS AND METHODS 
Preparation of powders 
The synthesis of silicon-carbonated HA (SiCHA) powders was performed 
based on a nanoemulsion method at ambient temperature described elsewhere [27]. 
Acetone was used as organic solvent to create the nanoemulsion phase. An acetone 
solution of calcium nitrate tetrahydrate, Ca(NO3)2.4H2O (99.0% pure) was added 
dropwise into the di-ammonium hydrogen phosphate, (NH4)2HPO4 (98.0% pure), 
ammonium hydrogen carbonate, NH4HCO3 (99.0% pure) and silicon tetra acetate, 
Si(CH3COO)4 (98.0% pure) in aqueous solution; all reactants were purchased from 
Sigma-Aldrich. Four different groups of powders with different CO3 (x) and Si (y) 
molar contents were synthesized in this work: CO3-substituted HA (CHA), Si-
substituted HA (SiHA) and silicon-carbonated HA (SiCHA-1 and SiCHA-2), as 
shown in Table 1. The general formula for the synthesized powders can be written as 
follows: 
CHA Ca10-x/2 (PO4)6-x (CO3)x (OH)2 (1) 
SiHA Ca10 (PO4)6-y (SiO4)y(OH)2-y (2) 
SiCHA Ca10-x/2 (PO4)6-x –y (CO3)x (SiO4)y (OH)2-y (3) 
 
Prior to production of SiCHA powders, pure CHA and SiHA were synthesized 
to optimize the composition of CO3- and Si- substituted into the apatite structure. The 
compositions of the pure CHA (x= 2.0) and SiHA (y= 0.3 and 0.5) powders were 
6 
 
chosen to closely mimic the composition of CO3- and Si in bone mineral; these 
powders then used as the control compositions.  
Calcination was then performed on the as-synthesized powders at 500, 600 
and 700°C with a heating rate of 10°C /min and at least one hour soaking time in 
ambient atmosphere. 
 
Physical and chemical characterization techniques 
Physical and chemical characterizations were firstly performed to optimize the 
calcination temperatures. Powders having the closest compositions to the natural 
human bone mineral were selected as the optimum condition.  
 
X-Ray Diffraction Analysis 
X-Ray Diffraction (XRD) was used to determine the crystallinity of powders 
after calcination. XRD was carried out using a Bruker D8 XRD with a copper anode 
(Cu Kα, λ=1.5406 Å) as X-Ray source. The range of x-ray scan was fixed from 
2θ=10° to 90°. HA standard pattern with ICDD file number of 09-0432 was used as 
the reference pattern. Data analyses were done using X’Pert HighScore Plus software. 
Lattice parameters and crystallite size were calculated based on Rietveld refinement.  
 
Fourier Transform Infra-Red Spectroscopy 
Fourier Transform Infra-Red (FTIR) Spectroscopy was used to identify any 
changes in the mechanisms of CO3 and Si ions substitution within the HA structure 
after calcination. The wavenumber range was 4000 to 650 cm-1; with a spectral 
resolution of Spectrum 100 Software. Each sample was scanned four times using 
transmittance mode. 
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Transmission Electron Microscopy 
Philips CM100 Transmission Electron Microscope (TEM) was used to 
examine the morphology of the calcined powders in terms of their particle size and 
shape. Prior imaging the samples, 0.1 mg of powders were suspended in pure water 
and sonicated for ten minutes to allow the powders to be well dispersed. A drop of the 
suspension was then carefully placed onto a copper grid (diameter=3.05 μm, 
mesh=400) and allowed to dry. Samples were imaged at a magnification of 130 kX at 
HV=100.0kV.  
 
Carbon, Hydrogen, Nitrogen Analysis 
The percentages of CO3 incorporated in the calcined powders were determined 
using Carbon, Hydrogen, Nitrogen (CHN) analysis using Carlo Erba 1180 Elemental 
Analyser controlled with CE Eager 200 Software, run in accordance to the 
manufacturer’s instruction and weighed using a certified Mettler MX5 Microbalance. 
The powders (1.5-2.0 mg) were combusted at high temperatures in a stream of 
oxygen, and the products of the combustion for carbon, hydrogen and nitrogen were 
measured by the instrument in a single analysis. In order to estimate the amount of 
CO3 present in the sample, the wt% of carbon obtain was multiplied by a factor of 
five [10, 32].  
 
Inductively Coupled Plasma-Optical Emission Spectroscopy Measurement 
0.01 g of the calcined powders was digested in 1 M HNO3 (2.5 mL of HNO3, 
1.5 mL of H2O2, and 0.3 mL of HCl ) in a 100 mL Erlenmeyer flask. The 
concentrations of Ca, P and Si in the calcined powders were determined by 
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inductively coupled plasma with optical emission spectroscopy (ICP-OES) using 
Perkin Elmer Optimal 4300DV instrument. 
 
X-Ray Fluorescence Analysis 
X-Ray Fluorescence (XRF) is an emission spectroscopic technique, which 
identify the elements present in the sample. The ratio of Ca/P and percentages of Si 
that successfully incorporated into the apatite structure were determined using XRF. 
The sample preparation and analysis of the calcined powders were performed at Glass 
Technology Service (GTS) in Sheffield. The elemental compositions in the powders 
were quantified using a Rigaku RIX-3000 wavelength dispersive XRF spectrometer. 
The 2910a sample (54.48% CaO, 41.25% P2O5, 0.21% SiO2, 0.043% Na, 0.011% Mg, 
0.094% Al, 0.078% Sr, 0.011% Fe and 0.01% Zr) was used as check standards for the 
analysis, which were run pre- and post-sample analyses to ensure the accuracy of the 
results obtained. 
 
In vitro biocompatibility assessment 
International Organization for Standardization (ISO) 10993-5: Biological 
Evaluation of Medical Devices, Part 5: Tests for Cytotoxicity, was adapted and used 
as guideline in this study. This test involved the study on the cell viability, 
proliferation, metabolic activity and early osteogenic differentiation of hMSCs in 
direct contact with the investigated samples. The in vitro biocompatibility test was 
performed only on the optimized calcined powders.  
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Sample Preparation 
As all samples tested were in powder form, aliquots of 0.05 g of the optimized 
calcined powders were sterilized in 1.0 mL of 70% industrial methylated spirit (IMS) 
for three hours followed by rinsing twice with PBS. 
 
Cell culture and seeding 
Human bone marrow derived-mesenchymal stem cells (hMSCs) obtained 
from a 24-year old male (Lonza, United States) at passage zero (P0) were expanded 
until passage two (P2) when the required cell number was obtained. Cells were 
cultured in high glucose expansion media consists of 4.5g/L Dulbecco’s Modified 
Eagle Medium, DMEM (Lonza, United Kingdom), 1% v/v L-glutamine (Lonza, 
United Kingdom), 1% v/v Penicilin-Streptomycin (Lonza, United Kingdom) and 10% 
v/v Fetal Bovine Serum (Biosera labtech, United Kingdom) followed by, incubation 
at humidified environment at 37°C with 5% CO2. hMSCs at passage 3 (P3) were 
seeded at 5X104 per well in a 24 well cell culture plate and allowed to adhere for three 
hours. Prior to direct contact of the powders with the seeded cells, 1.0 mL of 
osteogenic media was directly added into the aliquots containing 0.05 g of sterile 
powders, mixed well and carefully transferred to the relevant wells. Culture media 
was replenished every three days for 21 days. A glass pipette was used to carefully 
discard the media from the side of the relevant wells without disrupting the culture. In 
all cases, tissue culture plastic alone cultured in osteogenic media acts as the positive 
control (non-toxic) whilst negative control (toxic) consists of 0.1% Triton-X in high 
glucose expansion media. At 7, 14 and 21 days, cells were rinsed with Phosphate 
Buffer Saline, PBS (Sigma-Aldrich, United Kingdom), trypsinized, washed again 
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with PBS and samples were lysed in 1.0 mL of dH2O followed by being frozen at -
80°C. 
 
Cell viability 
The cell viability was observed using Confocal Laser Scanning Microscope 
(CLSM) Olympus Fluoview FV 1200 with Fluoview Version 4.1 software (Olympus, 
UK). The viability of the cells was assessed at 7, 14 and 21 days using the Live/Dead 
Assay Kit (Invitrogen, United Kingdom) according to the manufacturer’s instructions. 
Calcein-AM ester was used to fluorescently label viable cells (green); the nucleus of 
dead cells is labelled with Propidium Iodide (red). Briefly, cell culture media was 
removed from samples. They were washed with 1.0 mL PBS then immersed in 0.5 
mL PBS staining solution containing 10 µM Calcein-AM and 1 µM Propidium Iodide 
and incubated at 37°C for 20 minutes in the dark. The samples (n=1) were then 
washed once with 1.0 mL of PBS and immediately imaged using CLSM.  
 
Cells activity and proliferation 
The Quant-iTTM Picogreen® dsDNA assay kit (Invitrogen, United Kingdom) 
was used according to the manufacturer’s instruction. The Picogreen solution was 
prepared as 1: 200 dilutions in 1 X Tris-EDTA (TE) buffer. Ranges of DNA dilutions 
(0-2 μg/mL) were used to construct a standard curve. 100 µL of cell lysate or DNA 
standard was placed each well of a 96 well plate, followed by 100 µL of Picogreen 
reagent to each well. This was placed in the dark for 5 minutes before reading the 
fluorescence at 485/535 nm (excitation/emission) using Synergy II BioTek plate 
reader.  
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Alkaline phosphatase (ALP) activity was obtained from a 4-
Methylumbelliferyl phosphate, 4-MUP (Sigma-Aldrich, United Kingdom) reaction. 
Ranges of 4-Methylumbelliferone, 4-MU (Sigma-Aldrich, Switzerland) dilutions (0-2 
μg/mL) were used to construct a standard curve. 50 µL of the cell lysate from each 
sample or standard of 4-MU and 50 µL of 4-MUP was then added into the relevant 
well of 96 well plate to this followed by incubation at 37°C for 90 minutes. To 
terminate the reaction, 100 µL of 1 X TE was added and the reading of the 
fluorescence was taken at 360/440 nm (excitation/emission) using Synergy II BioTek 
plate reader.  
 
Cell metabolism 
The levels of total protein were quantified using Bradford reagent (Sigma-
Aldrich, United Kingdom). Ranges of protein standard solutions (0-2 mg/mL) were 
prepared by dissolving Bovine Serum Albumin, BSA (Sigma-Aldrich, United 
Kingdom) in distilled water. For total protein assay, 50 μL samples or standards were 
placed in each well of 96 well plates, followed by addition of 50 µL of Bradford 
reagent. Samples were incubated for 5 minutes at room temperature before reading 
the absorbance level at 595 nm using Synergy II BioTek plate reader.  
 
Statistical analysis  
Quantitative data were presented as means±standard deviation (SD). Data 
were initially tested for normality using the Kolmogorov-Smirnov test, with Dallal-
Wilkinson-Lillie for corrected P value. To determine any differences between 
powders group at each time point, a two-way ANOVA with multiple comparisons 
Tukey test was performed. Statistical significance was considered for p≤0.05 (*), 
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p≤0.01 (**), p≤0.001 (***) and p≤0.0001 (****).  For biochemical assays, tests were 
performed on n=3 in duplicate. All statistical analyses were performed using 
GraphPad Prism 7 software.  
 
RESULTS 
Physico-chemical characterizations 
XRD analysis 
Regardless of powder formulations, all powders remained stable in a single-
phase diffraction pattern, typical of hydroxyapatite, HA (ICDD: 09-0432). Varying 
the calcination temperature from 500°C to 700°C shows no obvious difference 
between the diffraction patterns as shown in Fig. 1. However, the crystallographic 
properties showed evident effects on the lattice parameters and crystallite size of the 
calcined powders (Table 2). There were eight main peaks detected, i.e. at about 
2θ=26° which was indexed at (002), 2θ=32-34° which represents three overlapped 
peaks of (211), (300) and (202), 2θ=39.8° indexed to (310), 2θ=49.4° for (222), and 
2θ= 50 and 53° indexed to (213) and (004), respectively. Powders containing 
carbonate demonstrated a contraction in a-axis and expnasion in c-axis while 
carbonate-free powders (SiHA) showed expansions in both a- and c-axes at any 
calcination temperature. No other phase of calcium phosphate, such as calcium oxide 
(2θ=37.3°) was traced even at high calcination temperature of 700°C.  
FTIR analysis 
The full FTIR spectra scanned at 650-4000 cm-1 and their typical bands of the 
CO3 and SiO4 ions substituted into the apatite structure are represented in Fig. 2 for 
CHA, SiHA, SiCHA-1 and SiCHA-2 powders calcined at 500-700°C. For CHA and 
SiHA powders (Fig. 2 a and b), the typical peaks of hydroxyl groups were detected at 
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3570 and 1643 cm-1, while only one main peak of hydroxyl was detected at 3570 cm-1 
for SiCHA-1 and SiCHA-2 calcined powders (Fig. 2c and d) [6, 32].  
All calcined powders showed the main characteristic bands of phosphate 
groups at about 960, 1020 and 1080 cm-1 as these are the most intense peaks in 
characterizing the hydroxyapatite crystals structure [33, 34]. The IR spectra also 
confirmed that there is no other secondary phase such as calcite ~712 cm-1, aragonite 
~713 and 700 cm-1 and vaterite ~745 cm-1 were observed for all samples [34, 35].  
All CHA calcined powders regardless of the calcination temperature produced 
bands corresponding to the B-type CHA at about 870-875, 1410-130 and 1450-1470 
cm-1 [12, 13, 36]. For SiCHA -1 and SiCHA-2 calcined powders, a missing band of 
CO3 at 870-875 cm-1 was observed and only two main bands of CO3 were found at 
1410-1430 and 1450-1470 cm-1. Despite of the missing band, no carbonation occurred 
at the hydroxyl sites (A-type CHA) which is normally detected at 877-880, 1500 and 
1540-1545 cm-1 [13, 33, 37] in any composition of the calcined powders at 700°C.  
The typical bands of Si-substituted HA (SiO4) structure were detected at 947 
and 880 cm-1 [26, 29] in the SiHA calcined powders at 500-700°C. Again, both 
SiCHA calcined powders demonstrated the absence of one of the Si-substituted HA 
band at about 947 cm-1. A careful inspection of the IR spectra shows a small band of 
SiO4 at 880-890 cm-1 for both SiCHA-1 and SiCHA-2 regardless the calcination 
temperature. Since the band of SiO4 appears to be too small to be observed on the 
spectra, the results of FTIR analysis of the calcined powders was listed in Table 3 for 
a clear comparison between the samples. 
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TEM imaging 
The TEM micrographs of the calcined powders at 500°C are shown in Fig. 3. 
The CHA powders appeared to be more spherical (20-30 nm length, 10-30 nm width) 
compared to pure SiHA, which have elongated rod-like particles (50-100 nm length, 
15-30 nm width). At 500°C, both SiCHA-1 and SiCHA-2 powders produced particles 
with dimensions which fall in the range of 30-50 nm length and 15-30 nm width, 
perfectly matching the dimension of biological apatites [38]. The particle sizes of the 
calcined powders correlates well with the crystallite sizes obtained from XRD 
analysis, where the same trends were seen in both analyses.   
 
CHN analysis 
CHN analysis clearly demonstrated that the CO3-substituted HA calcined 
powders, namely the CHA, SiCHA-1 and SiCHA-2 exhibited the loss of CO3 as the 
temperature increased (Table 4). For example, even at a low calcination temperature 
of 500°C, there is about 21% CO3 loss from the CHA powders; a similar trend is seen 
for SiCHA-1 and SiCHA-2. While, CO3-free HA (SiHA) calcined powders showed an 
increment in the percentage of CO3 with increasing temperature. However, the 
percentage of CO3 present in the SiHA calcined powder is relatively low as compared 
to the CO3-substituted HA powders given any calcination temperature.  
 
Elemental analysis 
The ICP-OES and XRF elemental analyses suggested that the ionic 
substitutions either the CO3 and/or Si have a significant effect on the ratio of Ca/P. 
The ratio of Ca/P obtained for all the calcined powders are significantly higher than 
the stoichiometric HA which is 1.67. Higher amount of Si was detected in SiCHA-1 
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as compared to SiHA and SiCHA-2 at all given calcination temperatures. Regardless 
of the powder formulation, all Si-substituted HA powders contains <1wt% Si 
incorporated in the HA lattice (Table 5). It was stated that the amount of Si present in 
vivo within the mineralising osteoid regions was 0.5wt% by Carlisle (1970) [20]. 
Hence, the SiCHA produced in this work could be considered comparable to the 
mineral content found in bone in vivo.  
 
In vitro biocompatibility test 
Using the physico-chemical characterizations, a calcination temperature of 
500°C was chosen as the optimal calcination temperature and the optimum powder 
compositions were CHA, SiHA, SiCHA-1 and SiCHA-2. The osteogenic effects of 
these optimised powders were then investigated using human bone marrow-derived 
mesenchymal stem cells (hMSCs). 
 
Cell viability 
CLSM images for the controls and calcined powders at 500°C after 7, 14 and 
21 days in culture are presented in Fig. 4. Cells in direct contact particularly with 
CHA, SiHA and SiCHA-2 powders demonstrated an elongated fibroblast-like 
morphology consistent with the positive control at each time-point. While, SiCHA-1 
revealed a lower proportion of live cells relative to SiCHA-2, SiHA and CHA 
powders throughout the culture. However, none of the tested powders demonstrated a 
toxic effect, indicated by rounded cell nucleus as observed in the negative control.   
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Cell proliferation and osteogenic activity 
The obtained DNA concentrations suggested that all the investigated powders 
stimulated cell proliferation (Fig. 5 a). When comparing the powders with each other 
there was no significant difference between SiCHA-1, CHA and SiHA on day 7, but 
SiCHA-2 was significantly higher over SiCHA-1 (p=0.0021). Overall, SiCHA-2 
showed the highest DNA concentrations compared to all other investigated groups 
(TCP and powders) on day 14 and day 21 (p ≤ 0.0001).  
ALP activity was clearly increased over time for all the tested powders (Fig. 5 
b) with cells cultured on SiCHA-2 showed the highest mean ALP/DNA at either time-
point (p≤0.0001). Between the single substitution powders, CHA showed 
significantly higher levels of mean ALP/DNA relative to SiHA as culture progressed 
(p≤0.0001). SiCHA-1 demonstrated similar trend to CHA, where the levels of 
ALP/DNA of SiCHA-1 significantly higher as compared to SiHA on day 14 
(p=0.0047) and day 21 (p=0.0007).  
 
Total protein production 
The total protein production followed the behaviour of cell number indicates 
by the DNA concentrations where SiCHA-1 had the lowest levels mean total protein 
among the tested powders but still significantly higher compared to TCP on day 7 
(p=0.0006) and day 14 (p≤0.0001). However, the cells in direct contact with SiCHA-1 
produced lower level of total protein compared to TCP on day 21 (p≤0.0001). 
Overall, cells on SiCHA-2 produced the highest total protein compared to all other 
investigated groups (TCP and powders) on day 7, 14 and 21 (p≤0.0001).  
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DISCUSSION 
Chemical modification of HA through ionic substitution has demonstrated 
benefits in accelerating bone regeneration and facilitated cell-mediated resorption of 
the ceramic scaffold compared with the use of stoichiometric HA [6, 8]. However, the 
delivering of these ionic substitutions to the targeted cells should be in controlled 
amounts; mimicking as is presents in the native bone, i.e. carbonate (up to 8wt%), and 
silicon (up to 1wt%) besides calcium and phosphate as the major components [8, 19, 
39].  
SiCHA with different degrees of CO3 and Si ionic substitutions (were 
successfully produced in this study by chemical modification of the nanoemulsion 
method. Calcination treatment is a mandatory step for producing high performance 
scaffolds for BTE application. The main aim of calcination treatment is to ensure that 
the synthesis process is completed and any unreacted components incorporated during 
synthesis are eliminated [27, 40]. CO3 loss in air generally starts at 550°C and is 
completed above 900°C, depending on treatment-time and composition [13, 41]. 
Therefore, the calcination temperature was limited up to 700°C for 1 hour (soaking 
period) in this study to retain the CO3 content.  
The physical and chemical analyses established that simultaneous substitution 
of CO3 and Si ions into the HA lattice remained as pure single phase HA at 500 to 
700°C. The absence of (112) Miller’s plane, which usually appears on a standard HA 
diffraction pattern is typically attributed to the substitution of the ions into the HA 
structure [42]. The increased in the crystallite size of the powders with the increased 
of calcination temperature could be easily explained as higher calcination temperature 
leads to an increase in the atomic mobility, which gives rise in the grain growth 
resulting in a larger crystallite size.  
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The IR spectrum shows a clear comparison between CHA, SiHA and SiCHA 
after calcination. Both SiCHA calcined powders demonstrated similar characteristics 
with missing bands of CO3 and Si ions at 870-875 cm-1and 947 cm-1, which is one of 
the typical bands of B-type CHA and Si-substituted HA, respectively. These missing 
bands in SiCHA powders provide evidence of the competitive substitutions between 
the CO3 and Si ions into the phosphate sites.  
The low calcination temperature used in this work allow the powders to 
remain as B-type CHA and not transforming from B-type to more complex mixture of 
AB-type or A-type CHA. This phase transformation normally occurs when as-
synthesized powders are heat treated between 700-1200°C [32, 37, 43]. This indicated 
that the calcined powders produced in this study are thermally stable up to 700°C. 
Surprisingly, carbonate-free substituted HA (SiHA) powders showed an 
increment in the percentage of CO3 as the calcination temperature increased but was 
not detected in the IR spectra. This means that the CO2 from the atmosphere was 
absorbed only on the surface of the powders during calcination and not incorporated 
in the crystal structure. The small amount of CO3 in SiHA might also be due to the 
presence of acetate group that would have remained from the silicon acetate precursor 
[32]. In order to prevent any carbonation in the SiHA structure, the calcination of the 
powders could be performed in argon atmosphere instead of air [2]. At this stage of 
study, we concluded that 500°C was chosen as the optimum condition to produce 
highly controlable amounts of CO3- and/or Si-substituted HA nanopowders which 
remained as single phase B-type CHA and possess similar composition to the 
inorganic components of bone mineral.  
The surface morphologies of the optimised powders were found to be 
relatively differences in the particles size and shape, due to the differences in ionic 
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substitutions. The presence of high CO3 concentrations in the CHA powders caused 
the powders to be more spherical; which is a similar observation made by Zhou et al. 
(2008) [27]. On the other hand, SiHA powders possess more elongated and larger 
particle size with about 80-100 nm in length. Both SiCHA powders produced in this 
study perfectly matched the dimensions of the biological apatite with particle sizes 
falling in the range of 30-50 nm in length and 15-30 nm in width [38]. It is important 
to ensure that the powders produced are at the nanoscale level in particular for BTE 
applications as it directly affects the mechanical and biological performances of the 
end products. It was shown in literature that nanoparticle apatite greatly influences 
variety of metabolic functions and remodelling processes [44]. For instance, in vitro 
tests of fibroblast and osteoblasts cells on the nanocrystalline octacalcium phosphate 
(OCP) coatings, proved that both cell types could adhered, formed a normal 
morphology, proliferated and remained viable, thus supporting a good 
biocompatibility and absence of any toxicity effects.  
Despite their composition, no sign of toxicity was evident from any of the 
powders using a direct contact method with hMSCs. It was previously reported that 
the toxicity of a material is mainly caused by either the release of ions or compounds, 
or worn debris from the ceramic material itself [45]. In the present finding, we 
observed that the cells in direct contact with SiCHA-1 powders were less confluent 
than the other tested powders at each time-point. This is due to high ion released from 
SiCHA-1 powders as it contains the highest Si (0.58wt%) content among them. This 
abrupt ion released at early stage of culture (before 7 days) could have a negative 
impact on the cell viability, which caused in a slight loss of cells [8]. This is because 
some of the hMSCs were detached from the powders and resulted in suspended cells 
present in the media. Being an anchorage-dependent cells, hMSCs need a substrate to 
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attach and survive. When the detached cells were in suspension, they were floating 
and might have been discarded during media changed. Thus, less dead cells shown by 
the live/dead staining particularly on day 7 as compared to other tested powders. But, 
the population of the viable cells in direct contact with SiCHA-1 were found to 
remains low at every time point. However, <30% of cell death were found on all the 
exposed powders at 21 days. According to ISO 10993-5, a reduction of >30% 
viability is considered as cytotoxic. Thus, SiCHA-1 prepared in this study is 
considered as non-toxic, but is hindering the proliferation of hMSCs. Similar 
observation was reported by Landi et al. (2010) in their finding, where 0.8wt% Si in 
SiCHA powders caused a toxic effect on the human osteoblast cells, while SiCHA 
powders with lower Si content (0.55wt%) inhibited the proliferation of human 
osteoblast, but after 7 days of culture, powders were not considered to be toxic [8]. 
The higher the Si content incorporated in the HA structure, the higher the cell death. 
This is due to higher ion release as powders with high Si content have higher 
solubility [46, 47]. In this work, SiCHA-2 which contain <0.55wt% Si shows higher 
cell viability compared to SiCHA-1 with >0.55wt% Si. The same trend is also shown 
quantitatively by the DNA concentrations (Fig. 5a), which indicates the number of 
cell population.  
After 21 days culture, SiCHA-2 shows the highest level of ALP/DNA ratio, 
which indicates the powder may stimulate osteogenic behaviour to greater extent than 
other powders. Botelho et al. (2006) found a similar behaviour up to 21 days and 
decreased in the ratio of ALP/COL I after 27 days treatment, which was related to the 
onset of mineralization [48]. However, the later trend was not observed in this study 
as the culture was terminated on day 21. Further work in the future, including 
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immunostaining, qPCR and flow cytometry would provide better indications for the 
osteogenic bone markers.  
Carbonate-substituted HA appeared to perform better than other powders in 
the production of total protein after 21 days culture. This indicated that hMSCs were 
the most metabolically active when in contact with CHA powders. Higher CO3 
content resulted in higher metabolic activity of the particular cells/tissues [49-51]. For 
instance, bone, which is very active tissue, contained higher CO3 compared to almost 
inert enamel [7, 8]. When comparing the SiCHA powders, SiCHA-2 shows relatively 
higher protein production than SiCHA-1. This is related to the cell number as 
represented by the amount of DNA obtained. Essentially, as the cell population 
increases in size so does the quantity of total protein. In addition, SiCHA-2 powders 
contained higher CO3 content as compared to SiCHA-1.  
 
CONCLUSIONS 
The solubility-reactivity and biomaterial-cell interactive surfaces are two key 
points in determining the cell survival and response. Thus, controlled amounts of the 
ionic substitutions into the apatite structure are mandatory in order to promote the 
desired osteoblast behaviour. In this study, powders with 3.98wt% carbonate and 
0.45wt% Si-substituted HA namely, SiCHA-2, shows the closest compositions to the 
physiological range of ionic substitutions in bone mineral, thus, make it the most 
favourable growth environment for hMSCs up to 21 days culture in vitro. These 
powders were associated with the most rapid proliferation of cells showed the 
strongest potential for osteogenic activity (ALP/DNA ratio). hMSCs also produced 
more proteinaceous material and were most metabolically active in direct contact with 
SiCHA-2 as compared to SiCHA-1. It can be concluded at this point that, among the 
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tested powders, SiCHA-2 was the best powder formulation and that it was suitable for 
the next phase in the development of a novel 3D SiCHA scaffold for BTE.  
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FIGURE TITLES AND LEGENDS 
Figure 1.  
XRD analysis of the calcined powders at 500-700°C; (a) CHA; (b) SiHA; (c) SiCHA-
1; (d) SiCHA-2, demonstrating single phase of HA without the formation of 
secondary phase. Regardless of the powders composition, no obivious differences 
were observed between the diffraction patterns at any given calcination temperature.  
 
Figure 2. 
FTIR spectra of (a) CHA, (b) SiHA, (c) SiCHA-1 and (d) SiCHA-2 calcined powders 
at 500-700°C and their typical bands of the carbonate and silicon ions substituted into 
the apatite structure, respectively. Regardless of the calcination temperatures, three 
major bands of CO3 were observed for the CHA powders, whilst only two vibration 
bands detected for both SiCHA powders. CO3-free powders (SiHA) exhited no CO3 
bands besides the two typical Si-substituted vibration bands. At any given calcination 
temperature, SiCHA-1 and SiCHA-2 shows a missing band of SiO4, indicating the 
evidence of the competitive substitutions between CO3 and/or Si into the phosphate 
sites.  
 
Figure 3. 
TEM images of the optimum calcined powders calcined at 500°C; (a) CHA; (b) 
SiHA; (c) SiCHA-1; (d) SiCHA-2. The particle sizes of the calcined powders 
correlates well with the crystallite sizes obtained from XRD analysis, where the same 
trends were seen in both analyses. Scale bar = 100 nm. 
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Figure 4. 
CLSM images of the controls and optimum calcined powders of CHA, SiHA, 
SiCHA-1 and SiCHA-2 cultured in osteogenic media for 21 days. Green indicates 
viable cells and red indicates dead cells. Scale bar = 200 μm. ** PVE CTL= Positive 
control (hMSCs cultured in osteogenic media act as tissue culture plastic) and NVE 
CTL= Negative Control (hMSCs cultured in 0.1% Triton-X in high glucose expansion 
media). The population of viable cells in direct contact with SiCHA-1 was lower 
compared the other tested powders, but no toxicity effect occurred throughout the 
culture period.  
 
Figure 5. 
Effect of CHA, SiHA, SiCHA-1 and SiCHA-2 as-calcined powders on (a) cell 
proliferation indicated by the amount of DNA, (b) the ALP activity per unit cell 
(ALP/DNA) and (c) the levels of total protein production. Control represents the 
tissue culture plastic in osteogenic media (positive control). Values represent the 
mean±SD of three samples in duplicate. (*p≤0.05, **p≤ 0.01, ***p≤0.001, 
****p≤0.0001). Cells in direct contact with SiCHA-2 demonstrtaed the highest DNA 
concentrations and total protein production than the other tested powders and 
controls. The lower Si content in SiCHA-2 showed the highest ALP/DNA ratio after 
21 days culture with hMSCs, indicating that the powder may stimulate osteogenic 
behaviour to a greater extent than other powders. 
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TABLE TITLES AND LEGENDS 
Table 1.  
Different formulations of the prepared powders. 
Note: Provided no carbonation in A site occurred.  
 
Table 2. 
Lattice parameters and crystallite sizes of CHA, SiHA, SiCHA-1 and SiCHA-2 
powders at 500-700°C. Increasing the calcination temperature from 500 to 700°C 
altered the lattice parameters and increased the crystallite sizes of the calcined 
powders.  
Table 3. 
Results of FTIR analysis of the calcined powders at 500-700°C. Of the four different 
compositions investigates, SiCHA-1 and SiCHA-2 showed missing bands for CO3 
and Si using FTIR analysis. 
Table 4. 
CHN analysis of  the calcined powders at 500-700°C. Powders containing CO3 
showed CO3 loss as the calcination temperature increased. While, CO3-free powders 
demonstrated an increment in CO3 wt%, indicating the adsorption of CO2 from the 
atmosphere during calcination.  
Table 5. 
Elemental analyses of  the calcined powders at 500-700°C. The ratio of Ca/P obtained 
for all the tested powders are relatively higher than the stoichiometric HA (1.67), 
suggesting that the ionic substitutions either the CO3 and/or Si have a significant 
effect on Ca/P ratio. 
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Figure 5 
 
 
TABLES 
 
Table 1. Different formulations of the prepared powders. 
 
Sample 
codes 
CO3 (x) Si  (y) Powders formulation 
CHA 2.0 - Ca9(PO4)4 (CO3)2(OH)2 	
SiHA - 0.3 Ca10 (PO4)5.7 (SiO4)0.3 (OH)1.7    	
SiCHA-1 2.0 0.5 Ca9(PO4)3.5 (CO3)2 (SiO4)0.5 (OH)1.5  	
SiCHA-2 2.0 0.3 Ca9 (PO4)3.7 (CO3)2 (SiO4)0.3 (OH)1.7  	
 
Note: Provided no carbonation in A site occurred. 
 
 
Table 2. Lattice parameters and crystallite sizes of CHA, SiHA, SiCHA-1 and 
SiCHA-2 powders at 500-700°C. 
 
Samples Calcination 
temperature 
(°C) 
Lattice parameters (Å) Crystallite size 
(nm) a ± 0.003 c ± 0.003 
CHA 500 9.389 6.918 10.02 
600 9.367 6.920 17.83 
700 9.352 6.923 20.76 
SiHA 500 9.452 6.921 17.21 
600 9.455 6.923 21.02 
700 9.459 6.928 28.89 
SiCHA-1 500 9.399 6.901 12.86 
600 9.391 6.912 19.87 
700 9.387 6.918 23.73 
SiCHA-2 500 9.378 6.898 12.09 
600 9.372 6.893 18.92 
700 9.369 6.899 21.07 
 
 
Increasing the calcination temperature from 500 to 700°C altered the lattice 
parameters and increased the crystallite sizes of the calcined powders.  
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Table 3. Results of FTIR analysis of the calcined powders at 500-700°C. 
 
Samples T(°C) OH PO4 CO3 Si 
CHA 500 3573.0, 
1649.7 
962.9, 
1024.4, 
1083.3 
873.7, 
1414.8, 
1458.8 
- 
600 3573.3, 
1643.0 
962.5, 
1020.0, 
1080.0 
873.1, 
1414.8, 
1454.3 
- 
700 3573.5, 
1638.2 
962.3, 
1019.9, 
1081.2 
872.7, 
1417.1, 
1459. 9 
- 
SiHA 500 3562.5, 
1651.1 
963.2, 
1024.9, 
1086.4 
- 947.4, 
885.7 
600 3569.7, 
1635.8 
962.5, 
1024.7, 
1089.7 
- 946.9, 
883.5 
700 3570.9, 
1633.5 
962.4, 
1024.1, 
1090.1 
- 947.2, 
884.2 
SiCHA-1 500 3572.5 962.7, 
1027.7, 
1088.0 
1418.2, 
1461.9 
883.1 
600 3570.8 962.2, 
1022.9, 
1087.9 
1418.6, 
1461.8 
885.3 
700 3569.9 962.5, 
1023.5, 
1089.0 
1413.6, 
1461.9 
887.7 
SiCHA-2 500 3572.5 962.7, 
1027.7, 
1088.0 
1418.2, 
1461.9 
883.5 
600 3578.7 962.2, 
1022.9, 
1080.0 
1412.8, 
1461.8 
886.3 
700 3579.6 962.5, 
1023.5, 
1089.0 
1418.2, 
1461.3 
884.9 
 
 
Of the four different compositions investigates, SiCHA-1 and SiCHA-2 showed 
missing bands for CO3 and Si using FTIR analysis. 
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Table 4. CHN analysis of  the calcined powders at 500-700°C. 
  
Samples T(°C) %C (wt%) %CO3 (wt%) %CO3 changes 
after calcination 
(wt%) 
CHA 500 1.08 5.80 -21.63 
600 0.99 4.95 -33.11 
700 0.57 4.15 -43.92 
SiHA 500 0.01 0.05 +125.00 
600 0.02 0.08 +200.00 
700 0.02 0.12 +300.00 
SiCHA-1 500 0.48 2.90 -24.68 
600 0.42 2.25 -41.56 
700 0.36 1.90 -50.65 
SiCHA-2 500 0.79 3.98 -23.50 
600 0.50 3.25 -37.50 
700 0.38 2.98 -42.69 
 
 
Powders containing CO3 showed CO3 loss as the calcination temperature increased. 
While, CO3-free powders demonstrated an increment in CO3 wt%, indicating the 
adsorption of CO2 from the atmosphere during calcination 
 
 
Table 5. Elemental analyses of  the calcined powders at 500-700°C.  
 
Samples  T(°C) Ca/P 
Measured value 
(XRF) 
Si (wt%) 
Measured value 
(ICP-OES) 
CHA 500 1.76 - 
600 1.77 - 
700 1.79 - 
SiHA 500 1.71 0.49 
600 1.72 0.46 
700 1.74 0.41 
SiCHA-1 500 1.89 0.58 
600 1.91 0.47 
700 1.95 0.43 
SiCHA-2 500 1.86 0.45 
600 1.89 0.42 
700 1.92 0.40 
 
 
The ratio of Ca/P obtained for all the tested powders are relatively higher than the 
stoichiometric HA (1.67), suggesting that the ionic substitutions either the CO3 and/or 
Si have a significant effect on Ca/P ratio. 
 
 
 
